We created a broadcast CTV ad for Pfizer's Oxbryta, entirely featuring actual patients suffering from sickle cell disease, performing their daily routines.
Pfizer's Oxbryta is a prescription medicine used for the treatment of sickle cell disease.
After Avenue, formerly James Post, is a post-production company living on the intersection of production and culture. They are more than just another post house – they are your destination to bring the joy back into the content creation process, while maintaining the high caliber quality you expect. The new post house, led by award-winning edit duo Amy and Jonathan Eakin, represents cutting-edge talent and strategic partnerships that bring innovation to your doorstep in a crowded content game.